A Novel Treatment for Metastatic Prostate Cancer

Search text
Active Filters
Ieva Sutkeviciute
1 result
(0.07 seconds)
A structure-guided computational approach was used to identify allosteric druggable sites in PTHR and to predict compounds that would bind to this site, and Pitt researchers discovered four small-molecule compounds that act as negative allosteric modulators of PTHR signaling.
Parathyroid hormone (PTH) type 1 receptor (PTHR) is an indispensable G protein-coupled receptor (GPCR) of class B that functions to regulate blood levels of vitamin D, calcium, and phosphate ions in the body, as well as bone turnover.
A structure-guided computational approach was used to identify allosteric druggable sites in PTHR and to predict compounds that would bind to this site, and Pitt researchers discovered four small-molecule compounds that act as negative allosteric modulators of PTHR signaling.
    • Technology Type
      • 1
        Therapeutic Modality
      • Add ...
    • Technology Subtype
      • 1
        Small Molecule
      • Add ...
    • Therapeutic Areas
      • 1
        Endocrinology and Metabolic Diseases
      • 1
        Musculoskeletal
      • Add ...
    • Therapeutic Indications
      • Add ...
    • Tags
      • 1
        Bioinformatics
      • 1
        Small molecule
      • Add ...
    • Lead Inventor
      • 2
        Kazunori Koide
      • 2
        Thomas Smithgall
      • 2
        Xiaosong Wang
      • 1
        Alexander Deiters
      • 1
        Alexander Doemling
      • 1
        Ieva Sutkeviciute
      • Add ...
    • Department
      • 1
        Med-Pharmacology and Chemical Biology
      • Add ...
    • All Tech Innovators
      • 1
        Ieva Sutkeviciute
      • 1
        Ivet Bahar
      • 1
        Jean-Pierre Pierre Vilardaga
      • 1
        Jiyoung Lee
      • 1
        Pemra Doruker
      • Add ...
    • Date Submitted
This site uses cookies to deliver a better user experience. Learn more.